235 related articles for article (PubMed ID: 8116700)
1. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
3. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
[TBL] [Abstract][Full Text] [Related]
4. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
5. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
6. Treatment of preterm labor with the oxytocin antagonist atosiban.
Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.
Goodwin TM; Millar L; North L; Abrams LS; Weglein RC; Holland ML
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):913-7. PubMed ID: 7573268
[TBL] [Abstract][Full Text] [Related]
8. Atosiban.
Shubert PJ
Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
[TBL] [Abstract][Full Text] [Related]
10. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
Goodwin TM; Valenzuela GJ; Silver H; Creasy G
Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
[TBL] [Abstract][Full Text] [Related]
11. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
Saade GR; Shennan A; Beach KJ; Hadar E; Parilla BV; Snidow J; Powell M; Montague TH; Liu F; Komatsu Y; McKain L; Thornton S
Am J Perinatol; 2021 Aug; 38(S 01):e309-e317. PubMed ID: 32380566
[TBL] [Abstract][Full Text] [Related]
15. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptor antagonists for inhibiting preterm labour.
Papatsonis D; Flenady V; Cole S; Liley H
Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
[TBL] [Abstract][Full Text] [Related]
18. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
[TBL] [Abstract][Full Text] [Related]
19. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
[TBL] [Abstract][Full Text] [Related]
20. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]